Contractile protein phosphorylation predicts human heart disease phenotypes

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Biochemistry

Background:

• Human heart failure is linked to low thin-filament protein phosphorylation and increased calcium sensitivity.
• Previous studies relied on end-stage heart failure tissue, potentially limiting characterization.
• Diverse human tissue procurement methods may affect findings.

Purpose of the Study:

• To investigate stage-specific phosphorylation changes in sarcomeric proteins in human heart failure.
• To compare phosphorylation patterns in different heart failure phenotypes (hypertrophy vs. dilation).
• To identify potential diagnostic markers for progressive heart disease.

Main Methods:

• Analysis of cardiac left ventricular (LV) biopsy samples from patients with aortic stenosis.
• Categorization of patients into "Hypertrophy with preserved function" (Hyp) and "Dilation with reduced ejection fraction" (Dil) groups.
• Western blot analysis to quantify total and site-specific TnI and MLC2 phosphorylation, and protein phosphatase levels.

Main Results:

• In Hyp, total troponin I (TnI) phosphorylation increased, while myosin light chain 2 (MLC2) phosphorylation was unchanged compared to controls.
• In Dil, total TnI phosphorylation decreased, and MLC2 phosphorylation increased.
• Phenotype-specific TnI phosphorylation differences were observed at serine 22/23 (increased in Hyp) and serine 43 (decreased in Dil). Protein phosphatase-1 and -2 levels were reduced in Hyp and Dil, respectively.

Conclusions:

• Sarcomeric protein posttranslational modifications are stage-specific in progressive heart disease.
• These phosphorylation changes in TnI and MLC2 may serve as diagnostic indicators.
• Understanding these modifications could inform novel therapeutic strategies for heart failure.